Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Community Oncology Partners Selects House Rx as Its Strategic Partner for Enhanced Patient Care


News provided by

Community Oncology Partners

Sep 27, 2024, 13:40 ET

Share this article

Share toX

Share this article

Share toX

Community Oncology Partners
Community Oncology Partners

COP has chosen House Rx as its exclusive partner for medically integrated dispensing of necessary medications at its future oncology clinic sites. The initiative promises to improve access to medications, enhance patient outcomes and improve care within the communities it serves.

DOVER, Del. , Sept. 27, 2024 /PRNewswire-PRWeb/ -- Community Oncology Partners (COP), the owner-operator of medical oncology practices bringing the fight against cancer closer to home, today announced a partnership with House Rx, the leader in medically integrated dispensing to collaborate on in-office dispensing of oncology medications at future oncology clinics. This collaboration aims to enhance oncology care in underserved and rural areas by improving patient access to essential medications.

The COP growth platform model was built around giving providers long-term financial incentives to provide best-in-class care to our most vulnerable communities. This partnership will further enhance the support for providers and staff at future COP sites.

"Community Oncology Partners and House Rx aim to provide superior care through integrated medical and pharmacy care at the point of delivery," said Shaman Bakshi, CEO of Community Oncology Partners.

Post this

House Rx is driving the adoption of medically integrated dispensing in oncology practices. It achieves this by integrating pharmacists and specialized technology into clinic care teams, enhancing patient outcomes and also easing the burden of prescribing specialty therapies on providers. House Rx will be the exclusive provider of dispensing services and technology at COP clinics. Key benefits of the partnership include the following:

  • Enhanced Medication Access: Patients of COP's network clinics will benefit from easier and more affordable access to specialty medications.
  • Improved Patient Outcomes: With House Rx's support, COP practices will be able to ensure that patients start their therapies promptly and adhere to their treatment plan, leading to improved treatment outcomes.
  • Local Care: The partnership will provide an additional revenue stream that helps keep independent practices open in the communities they serve, enabling patients to receive high-quality care locally.
  • Dedicated Labor: House Rx will deploy its dedicated team of expert pharmacists and care coordinators to partner with clinic care teams to support the in-house dispensing programs, reducing the workload of already stretched-thin clinic staff.

"Our patients need to get their medications in an easier way than what exists today in underserved and rural communities," said Shaman Bakshi, CEO of Community Oncology Partners. "The last thing patients want to worry about during an infusion appointment is their prescription medications and any related side effects. Community Oncology Partners and House Rx aim to provide superior care through integrated medical and pharmacy care at the point of delivery."

For Community Oncology Partners to meet its goal of owning and operating 300+ sites across the country, the companies with which it partners to support patients, providers and staff are critical to its success.

To support its specialty pharmacy and medically integrated dispensing effort, Community Oncology Partners has entered into a multiyear relationship with House Rx to provide technology, analytics and labor support to its care teams. This partnership will allow COP to serve its communities with full physician and pharmacist collaboration for its cancer and blood disorder patients across all of its sites in every state in which it operates. Through this partnership, COP aims to achieve stronger patient engagement, adherence to medications and patient education, along with fewer side-effect-related ER visits.

"The House Rx vision is fully aligned with Community Oncology Partners' vision to provide its patients with a more local, more trusted and more cost-effective experience," Bakshi said.

"This partnership will allow us to know that a patient leaving our clinics can go straight home to rest with medications in hand with their questions answered," said Nathan Ure, COO of Community Oncology Partners. "It gives me so much joy to think of these patients and families escaping that additional strain when they need to heal."

"We are thrilled to support Community Oncology Partners and its mission to bring cancer care closer to home. Their vision to empower clinics to provide excellent, evidence-based care for each patient in underserved communities really resonated with us," said Alerie Stiles, SVP of Commercial Growth at House Rx. "Our collaboration will support COP's initiatives with not only modern specialty pharmacy technology but also with the necessary administrative and clinical labor needed to make its mission a success."

COP is currently in the design and development stage of its state-of-the-art care centers. Its goals include improving patient outcomes and experiences, improving physician and staff recruitment and retention and supporting the communities it serves with best-in-class oncology care closer to home.

For more information, please contact Jen Gallacher at (385) 335-8791 or [email protected].

About Community Oncology Partners
Community Oncology Partners is a growth platform with the singular focus of developing and operating oncology clinics with best-in-class care. Our mission is to ensure access to state-of-the-art, high-quality and affordable cancer care in a community-based setting. We strive to offer value to patients and payers alike while delivering integrated care via the Oncology Medical Home model. Our vision is to continuously advance cancer care, setting the gold standard in innovation, research and compassionate treatment. To start a conversation about cancer care in your community, visit us at http://www.cophealthcare.com.

About House Rx
House Rx is a healthcare technology and services company focused on making specialty medication more accessible and affordable for those suffering from chronic illnesses like cancer and autoimmune disorders. House Rx provides clinics with specialized technology and support from pharmacists and care coordinators to dispense medication directly to their patients, known as medically integrated dispensing (MID). House Rx's services are designed to help healthcare providers deliver value-based care and improve patient outcomes through efficient medication management. To learn more about House Rx, visit http://www.houserx.com.

Media Contact

Jen Gallacher, Community Oncology Partners, (385) 335-8791, [email protected], https://www.cophealthcare.com/

SOURCE Community Oncology Partners

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.